Search results
Results from the WOW.Com Content Network
Proximal diabetic neuropathy, also known as diabetic amyotrophy, is a complication of diabetes mellitus that affects the nerves that supply the thighs, hips, buttocks and/or lower legs. Proximal diabetic neuropathy is a type of diabetic neuropathy characterized by muscle wasting, weakness, pain, or changes in sensation/numbness of the leg.
Symptoms are typically unilateral, seen in about 78% of cases, but may be bilateral. [4] [2] The most common symptom is pain, paresthesias, or dysthesias on the anterolateral surface of the thigh that extends just above the knee. [3] [8] [5] [2] [6] [4] (The term "meralgia paraesthetica" combines four Greek roots to mean "thigh pain with ...
Paresthesia, also known as pins and needles, is an abnormal sensation of the skin (tingling, pricking, chilling, burning, numbness) with no apparent physical cause. [1] Paresthesia may be transient or chronic, and may have many possible underlying causes. [ 1 ]
Positive sensory symptoms are usually the earliest to occur, particularly tingling and neuropathic pain, followed or accompanied by reduced sensation or complete numbness. Muscle weakness and muscle atrophy may only be present if the entrapped nerve has motor fibers (some nerves are only sensory). Weakness and atrophy is a much less common ...
These symptoms include pain, weakness, and tingling of the legs, [5] which may radiate down the legs to the feet. [6] Additional symptoms in the legs may be fatigue, heaviness, weakness, a sensation of tingling, pricking, or numbness , and leg cramps, as well as bladder symptoms. [ 6 ]
Here are some symptoms everyone should be aware of: Rashes You may not think of your skin as an organ, but it is — and it can be affected by inflammation just like any other organ.
Hypoesthesia or numbness is a common side effect of various medical conditions that manifests as a reduced sense of touch or sensation, or a partial loss of sensitivity to sensory stimuli. In everyday speech this is generally referred to as numbness.
According to Lopate, et al., methylprednisolone is a viable treatment for chronic inflammatory demyelinative polyneuropathy (which can also be treated with intravenous immunoglobulin). The authors also indicate that prednisone has greater adverse effects in such treatment, as opposed to intermittent (high-doses) of the aforementioned medication.